ResearcherUniversity of TorontoActive in the last 2 years

Daniel K.C. Lee

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 9 November 2026

Matched on OpenAlex author ID A5020976927. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.70080 ↗
Phosphoinositide-focused CRISPR screen identifies novel genetic vulnerabilities in PDAC and AML cells Co-author DOI 10.1101/2024.09.09.612071 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Leonardo Salmena · 2 shared papers, 2024–2025 · strength 0.53
- Paper Phosphoinositide-focused CRISPR screen identifies novel genetic vulnerabilities in PDAC and AML cells DOI 10.1101/2024.09.09.612071 ↗
- Paper ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70080 ↗
Ché M.P. Melo · 1 shared paper, 2025 · strength 0.25
- Paper ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70080 ↗
Golam T. Saffi · 1 shared paper, 2025 · strength 0.25
- Paper ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. DOI 10.1002/1878-0261.70080 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.